TAK-653
| 製品名 | TAK-653 |
|---|---|
| CAS番号 | 1358751-06-0 |
| 分子式 | C21H19F3N4O2 |
| 分子量 | 416.4 g/mol |
| 外観 | 白色からオフホワイトの結晶性粉末 |
| 分析(HPLC) | ≥98.0% |
| 溶解度 | Soluble in DMSO, slightly soluble in ethanol, practically insoluble in water |
| ストレージ | Store at -20°C, protected from light and moisture |
| パッケージ | 10 mg, 50 mg, 100 mg, 500 mg, 1 g (or customized) |
お困りですか? 弊社チームまでお問い合わせください

同義語: TAK-653, TAK653, AMPA receptor potentiator, mGluR modulator, TAK-653 free base
In the fast-paced world of central nervous system drug discovery, the demand for highly selective, brain-penetrant compounds has never been greater. TAK-653 has emerged as a standout molecule, capturing the attention of researchers and pharmaceutical companies alike. As a potent and selective AMPA receptor potentiator, it offers a promising avenue for addressing cognitive deficits and neurological disorders, making it a hot commodity in both academic and industrial R&D pipelines.
TAK-653 is a synthetic small molecule developed by Takeda Pharmaceutical Company. It belongs to the class of ampakines, which are positive allosteric modulators of the AMPA receptor. Unlike traditional AMPA receptor agonists, TAK-653 does not cause receptor desensitization and exhibits excellent selectivity over other glutamate receptors. This profile makes it an invaluable tool for studying synaptic plasticity, learning, and memory.
Manufactured under strict quality control, TAK-653 is typically available at high purity (≥98% by HPLC) and is supplied as a white to off-white crystalline powder. Its favorable pharmacokinetic properties, including good oral bioavailability and brain penetration, have made it a leading candidate for clinical trials in treatment-resistant depression and cognitive impairment. For B2B buyers, sourcing TAK-653 from a reliable supplier ensures consistent quality and timely delivery for your research needs.
TAK-653 is a chemically synthesized compound with the molecular formula C21H19F3N4O2 and a molecular weight of 416.4 g/mol. It is a trifluoromethyl-substituted pyrazole derivative, designed to selectively potentiate AMPA receptor signaling. The compound is highly lipophilic, which facilitates its penetration through the blood-brain barrier.
Our TAK-653 is produced via a multi-step organic synthesis process, followed by rigorous purification to achieve ≥98% purity. Each batch is thoroughly tested for identity, purity, and residual solvents to meet the demands of preclinical and clinical research. The product is available in various pack sizes to accommodate different scale requirements, from milligram quantities for initial screening to gram-scale for animal studies.
| パラメータ | 仕様 |
|---|---|
| 分析(HPLC) | ≥98.0% |
| 外観 | 白色からオフホワイトの粉末 |
| 識別 | NMR, MS conform to structure |
| 乾燥減量 | ≤0.5% |
| 焼失残渣 | ≤0.11 TP3T |
| 重金属 | 10 ppm以下 |
| 残留溶剤 | Meets ICH guidelines |